Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens

被引:38
作者
Zhang, YQ
vanNeerven, RJJ
Kasran, A
deBoer, M
Ceuppens, JL
机构
[1] CATHOLIC UNIV LEUVEN, DEPT PATHOPHYSIOL, EXPTL IMMUNOL LAB, B-3000 LOUVAIN, BELGIUM
[2] UNIV AMSTERDAM, ACAD MED CTR, CELL BIOL & HISTOL LAB, 1105 AZ AMSTERDAM, NETHERLANDS
[3] INNOGENET NV, DEPT IMMUNOL, GHENT, BELGIUM
关键词
B7; CD28; CD80; CD86; co-stimulatory signals; cytokines; memory T cells;
D O I
10.1093/intimm/8.1.37
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The interaction between CD28 on T cells with CD80 (B7-1) and CD86 (B7-2) on APCs is considered to be of critical importance for primary T cell activation both in vivo and in vitro. The relative importance of this co-stimulatory signal in memory T cell activation is, however, less clear, and was therefore studied by in vitro experiments on T cell responses to soluble recall antigens using peripheral blood mononuclear cells or T cell clones, Our data demonstrate that B7-2 represents the major co-stimulatory signal for the activation of resting peripheral blood memory T cells with recall antigens, as evidenced by the effects of anti-B7-1 and anti-B7-2 on T cell proliferation as well as on IL-2 and INF-gamma production, Since CTLA-4-Ig and anti-CD28 Fab fragments had similar inhibitory effects to the combination of anti-B7-1 plus anti-B7-2, the involvement of a third cc-stimulatory CD28/CTLA-4 ligand is unlikely, Despite the strong effects of B7-blocking agents, a variable fraction of the memory T cells was resistant to inhibition. Moreover, T cell clones or in vitro preactivated T cells could efficiently be restimulated by soluble antigens on autologous APCs in the absence of B7-1 or B7-2 co-stimulation. These data show that most memory T cells that are freshly isolated from the blood are still dependent on CD28 triggering for their activation. However, recently activated T cells can apparently bypass the requirement for B7 and use other costimulatory signals for reactivation, a finding with important implications for the development of immunosuppressive strategies.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 44 条
  • [1] B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28
    AZUMA, M
    ITO, D
    YAGITA, H
    OKUMURA, K
    PHILLIPS, JH
    LANIER, LL
    SOMOZA, C
    [J]. NATURE, 1993, 366 (6450) : 76 - 79
  • [2] FCR CROSS-LINKING ON MONOCYTES RESULTS IN IMPAIRED T-CELL STIMULATORY CAPACITY
    BARCY, S
    WETTENDORFF, M
    LEO, O
    URBAIN, J
    KRUGER, M
    CEUPPENS, JL
    DEBOER, M
    [J]. INTERNATIONAL IMMUNOLOGY, 1995, 7 (02) : 179 - 189
  • [3] MORE EXACT QUANTIFICATION OF INTERLEUKIN-2 PRODUCTION BY ADDITION OF ANTI-TAC MONOCLONAL-ANTIBODY TO CULTURES OF STIMULATED LYMPHOCYTES
    BAROJA, ML
    CEUPPENS, JL
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 98 (02) : 267 - 270
  • [4] BOUSSIOTIS VA, 1993, P NATL ACAD SCI USA, V90, P11059, DOI 10.1073/pnas.90.23.11059
  • [5] B7 BUT NOT INTERCELLULAR-ADHESION MOLECULE-1 COSTIMULATION PREVENTS THE INDUCTION OF HUMAN ALLOANTIGEN-SPECIFIC TOLERANCE
    BOUSSIOTIS, VA
    FREEMAN, GJ
    GRAY, G
    GRIBBEN, J
    NADLER, LM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) : 1753 - 1763
  • [6] B70/B7-2 IS IDENTICAL TO CD86 AND IS THE MAJOR FUNCTIONAL LIGAND FOR CD28 EXPRESSED ON HUMAN DENDRITIC CELLS
    CAUX, C
    VANBERVLIET, B
    MASSACRIER, C
    AZUMA, M
    OKUMURA, K
    LANIER, LL
    BANCHEREAU, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) : 1841 - 1847
  • [7] FUNCTIONAL-CHARACTERIZATION OF A NOVEL ANTI-B7 MONOCLONAL-ANTIBODY
    DEBOER, M
    PARREN, P
    DOVE, J
    OSSENDORP, F
    VANDERHORST, G
    REEDER, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (12) : 3071 - 3075
  • [8] GENERATION OF MONOCLONAL-ANTIBODIES TO HUMAN LYMPHOCYTE CELL-SURFACE ANTIGENS USING INSECT CELLS EXPRESSING RECOMBINANT PROTEINS
    DEBOER, M
    CONROY, L
    MIN, HY
    KWEKKEBOOM, J
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 152 (01) : 15 - 23
  • [9] FAGNONI FF, 1995, IMMUNOLOGY, V85, P467
  • [10] FATTAH D, 1990, Cytokine, V2, P112, DOI 10.1016/1043-4666(90)90005-E